Viewing Study NCT06287918


Ignite Creation Date: 2025-12-25 @ 4:53 AM
Ignite Modification Date: 2025-12-26 @ 3:53 AM
Study NCT ID: NCT06287918
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-11-29
First Post: 2024-02-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations
Sponsor: 3H (Suzhou) Pharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module